by Michael Boyd | Aug 7, 2023 | Publications
Regulatory frameworks vary somewhat across geographies, but all basically evaluate whether a chemical possesses endocrine activity and whether this activity can result in adverse outcomes either to humans or to the environment. Current test systems include in silico,...
by Michael Boyd | Aug 7, 2023 | Publications
Various approaches are described for addressing the challenges associated with both the conduct and interpretation of these assays. Historical control data for both the AMA and FSTRA are presented to further understand background occurrences of histopathological...
by Michael Boyd | Jul 25, 2023 | Publications
Such assessments depend, at the outset, on a clear definition of what constitutes an EDC, understanding of the distinction between endocrine activity and endocrine disruption, and differentiation of endocrine-mediated effects from other likely mechanisms of action...
Recent Comments